Does the media refer more to HIMS or MD?

In the previous week, Hims & Hers Health had 44 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 51 mentions for Hims & Hers Health and 7 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.20 beat Hims & Hers Health's score of 0.16 indicating that Pediatrix Medical Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 9 Very Positive mention(s) 5 Positive mention(s) 30 Neutral mention(s) 5 Negative mention(s) 1 Very Negative mention(s) Neutral Pediatrix Medical Group 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MD or HNGE?

In the previous week, Pediatrix Medical Group had 4 more articles in the media than Hinge Health. MarketBeat recorded 7 mentions for Pediatrix Medical Group and 3 mentions for Hinge Health. Pediatrix Medical Group's average media sentiment score of 1.20 beat Hinge Health's score of 0.78 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor MD or CHE?

In the previous week, Chemed had 2 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 9 mentions for Chemed and 7 mentions for Pediatrix Medical Group. Chemed's average media sentiment score of 1.60 beat Pediatrix Medical Group's score of 1.20 indicating that Chemed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 9 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor RDNT or MD?

In the previous week, RadNet had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 10 mentions for RadNet and 7 mentions for Pediatrix Medical Group. RadNet's average media sentiment score of 1.57 beat Pediatrix Medical Group's score of 1.20 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Pediatrix Medical Group 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MD or BLLN?

In the previous week, Billiontoone had 6 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 13 mentions for Billiontoone and 7 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.20 beat Billiontoone's score of 0.26 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pediatrix Medical Group 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 4 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Pediatrix Medical Group (MD) Competitors

$27.03 +0.15 (+0.56%)

As of 03:58 PM Eastern

Compare

MD vs. HIMS, HNGE, CHE, RDNT, and BLLN

Should you buy Pediatrix Medical Group stock or one of its competitors? Pediatrix Medical Group's main competitors and comparable companies include Hims & Hers Health (HIMS), Hinge Health (HNGE), Chemed (CHE), RadNet (RDNT), and Billiontoone (BLLN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Pediatrix Medical Group compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Pediatrix Medical Group (NYSE:MD) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

In the previous week, Hims & Hers Health had 44 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 51 mentions for Hims & Hers Health and 7 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.20 beat Hims & Hers Health's score of 0.16 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	9 Very Positive mention(s)	5 Positive mention(s)	30 Neutral mention(s)	5 Negative mention(s)	1 Very Negative mention(s)	Neutral
Pediatrix Medical Group	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pediatrix Medical Group has a net margin of 8.96% compared to Hims & Hers Health's net margin of -5.51%. Pediatrix Medical Group's return on equity of 20.05% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-5.51%	-6.51%	-1.20%
Pediatrix Medical Group	8.96%	20.05%	8.15%

Hims & Hers Health currently has a consensus price target of $32.50, indicating a potential upside of 17.50%. Pediatrix Medical Group has a consensus price target of $25.00, indicating a potential downside of 7.51%. Given Hims & Hers Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Hims & Hers Health is more favorable than Pediatrix Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Pediatrix Medical Group	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Hims & Hers Health has a beta of 2.42, meaning that its share price is 142% more volatile than the broader market. Comparatively, Pediatrix Medical Group has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market.

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Pediatrix Medical Group has lower revenue, but higher earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.75	$128.37M	-$0.63	N/A
Pediatrix Medical Group	$1.91B	1.15	$165.39M	$2.09	12.93

Summary

Hims & Hers Health and Pediatrix Medical Group tied by winning 8 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Hinge Health?

Pediatrix Medical Group (NYSE:MD) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

Hinge Health has a net margin of 15.15% compared to Pediatrix Medical Group's net margin of 8.96%. Hinge Health's return on equity of 51.60% beat Pediatrix Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	8.96%	20.05%	8.15%
Hinge Health	15.15%	51.60%	14.16%

Pediatrix Medical Group has higher revenue and earnings than Hinge Health. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.91B	1.15	$165.39M	$2.09	12.93
Hinge Health	$587.86M	12.66	-$528.26M	$1.28	72.03

97.7% of Pediatrix Medical Group shares are owned by institutional investors. 1.8% of Pediatrix Medical Group shares are owned by insiders. Comparatively, 18.9% of Hinge Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Pediatrix Medical Group has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.38, indicating that its share price is 38% more volatile than the broader market.

In the previous week, Pediatrix Medical Group had 4 more articles in the media than Hinge Health. MarketBeat recorded 7 mentions for Pediatrix Medical Group and 3 mentions for Hinge Health. Pediatrix Medical Group's average media sentiment score of 1.20 beat Hinge Health's score of 0.78 indicating that Pediatrix Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hinge Health	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Pediatrix Medical Group currently has a consensus price target of $25.00, suggesting a potential downside of 7.51%. Hinge Health has a consensus price target of $100.57, suggesting a potential upside of 9.08%. Given Hinge Health's stronger consensus rating and higher possible upside, analysts clearly believe Hinge Health is more favorable than Pediatrix Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83

Summary

Hinge Health beats Pediatrix Medical Group on 11 of the 17 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Chemed?

Pediatrix Medical Group (NYSE:MD) and Chemed (NYSE:CHE) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings.

Chemed has a net margin of 10.60% compared to Pediatrix Medical Group's net margin of 8.96%. Chemed's return on equity of 31.77% beat Pediatrix Medical Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	8.96%	20.05%	8.15%
Chemed	10.60%	31.77%	18.90%

97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 95.9% of Chemed shares are owned by institutional investors. 1.8% of Pediatrix Medical Group shares are owned by company insiders. Comparatively, 3.3% of Chemed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Pediatrix Medical Group presently has a consensus target price of $25.00, suggesting a potential downside of 7.51%. Chemed has a consensus target price of $530.75, suggesting a potential upside of 1.91%. Given Chemed's stronger consensus rating and higher probable upside, analysts plainly believe Chemed is more favorable than Pediatrix Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Chemed	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Pediatrix Medical Group has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, Chemed has a beta of 0.51, suggesting that its stock price is 49% less volatile than the broader market.

Chemed has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.91B	1.15	$165.39M	$2.09	12.93
Chemed	$2.53B	2.69	$265.24M	$19.91	26.16

In the previous week, Chemed had 2 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 9 mentions for Chemed and 7 mentions for Pediatrix Medical Group. Chemed's average media sentiment score of 1.60 beat Pediatrix Medical Group's score of 1.20 indicating that Chemed is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	9 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Chemed beats Pediatrix Medical Group on 14 of the 16 factors compared between the two stocks.

How does Pediatrix Medical Group compare to RadNet?

RadNet (NASDAQ:RDNT) and Pediatrix Medical Group (NYSE:MD) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, risk, institutional ownership and earnings.

RadNet currently has a consensus price target of $90.00, suggesting a potential upside of 22.10%. Pediatrix Medical Group has a consensus price target of $25.00, suggesting a potential downside of 7.51%. Given RadNet's stronger consensus rating and higher possible upside, equities analysts plainly believe RadNet is more favorable than Pediatrix Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Pediatrix Medical Group	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Pediatrix Medical Group has a net margin of 8.96% compared to RadNet's net margin of -0.93%. Pediatrix Medical Group's return on equity of 20.05% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
Pediatrix Medical Group	8.96%	20.05%	8.15%

Pediatrix Medical Group has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Pediatrix Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.84	-$18.65M	-$0.27	N/A
Pediatrix Medical Group	$1.91B	1.15	$165.39M	$2.09	12.93

RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market. Comparatively, Pediatrix Medical Group has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market.

In the previous week, RadNet had 3 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 10 mentions for RadNet and 7 mentions for Pediatrix Medical Group. RadNet's average media sentiment score of 1.57 beat Pediatrix Medical Group's score of 1.20 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	9 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Pediatrix Medical Group	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

77.9% of RadNet shares are held by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Comparatively, 1.8% of Pediatrix Medical Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

RadNet beats Pediatrix Medical Group on 10 of the 17 factors compared between the two stocks.

How does Pediatrix Medical Group compare to Billiontoone?

Pediatrix Medical Group (NYSE:MD) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, media sentiment, dividends, profitability and analyst recommendations.

97.7% of Pediatrix Medical Group shares are held by institutional investors. 1.8% of Pediatrix Medical Group shares are held by company insiders. Comparatively, 50.2% of Billiontoone shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Billiontoone had 6 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 13 mentions for Billiontoone and 7 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.20 beat Billiontoone's score of 0.26 indicating that Pediatrix Medical Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pediatrix Medical Group	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	4 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pediatrix Medical Group currently has a consensus target price of $25.00, suggesting a potential downside of 7.51%. Billiontoone has a consensus target price of $125.88, suggesting a potential upside of 26.65%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts plainly believe Billiontoone is more favorable than Pediatrix Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pediatrix Medical Group	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Billiontoone	2 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.45

Pediatrix Medical Group has higher revenue and earnings than Billiontoone. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pediatrix Medical Group	$1.91B	1.15	$165.39M	$2.09	12.93
Billiontoone	$305.11M	15.37	$7.45M	$0.70	141.99

Pediatrix Medical Group has a net margin of 8.96% compared to Billiontoone's net margin of 8.04%. Pediatrix Medical Group's return on equity of 20.05% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pediatrix Medical Group	8.96%	20.05%	8.15%
Billiontoone	8.04%	9.96%	5.35%

Summary

Pediatrix Medical Group beats Billiontoone on 8 of the 15 factors compared between the two stocks.

Get Pediatrix Medical Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MD vs. The Competition

Export

Metric	Pediatrix Medical Group	Healthcare Providers & Services Industry	Healthcare Sector	NYSE Exchange
Market Cap	$2.20B	$10.00B	$7.17B	$23.48B
Dividend Yield	N/A	2.56%	2.53%	3.73%
P/E Ratio	12.93	34.59	272.99	29.41
Price / Sales	1.15	4.96	618.43	19.79
Price / Cash	12.02	120.90	77.82	32.15
Price / Book	2.49	3.99	12.85	7.60
Net Income	$165.39M	$313.25M	$3.47B	$1.07B
7 Day Performance	1.39%	1.13%	1.56%	-0.07%
1 Month Performance	9.39%	0.39%	5.86%	-0.42%
1 Year Performance	59.06%	15.69%	25.75%	13.25%

Pediatrix Medical Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MD Pediatrix Medical Group	1.6795 of 5 stars	$27.03 +0.6%	$25.00 -7.5%	+62.0%	$2.20B	$1.91B	12.93	4,315
HIMS Hims & Hers Health	2.4983 of 5 stars	$32.34 +4.1%	$32.50 +0.5%	-37.6%	$7.55B	$2.35B	N/A	2,442	Trending News
HNGE Hinge Health	3.5123 of 5 stars	$91.38 +1.6%	$100.57 +10.1%	+58.8%	$7.40B	$587.86M	71.67	1,437
CHE Chemed	3.6733 of 5 stars	$541.34 0.0%	$530.75 -2.0%	+14.4%	$7.09B	$2.53B	27.23	15,811	Positive News
RDNT RadNet	4.1428 of 5 stars	$76.41 +2.3%	$88.00 +15.2%	+5.2%	$5.99B	$2.27B	N/A	11,264	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MD) was last updated on 9/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Pediatrix Medical Group (MD) Competitors

MD vs. HIMS, HNGE, CHE, RDNT, and BLLN

How does Pediatrix Medical Group compare to Hims & Hers Health?

Summary

How does Pediatrix Medical Group compare to Hinge Health?

Summary

How does Pediatrix Medical Group compare to Chemed?

Summary

How does Pediatrix Medical Group compare to RadNet?

Summary

How does Pediatrix Medical Group compare to Billiontoone?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MD vs. The Competition

Pediatrix Medical Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Pediatrix Medical Group (MD) Competitors

MD vs. HIMS, HNGE, CHE, RDNT, and BLLN

How does Pediatrix Medical Group compare to Hims & Hers Health?

Does the media refer more to HIMS or MD?

Is HIMS or MD more profitable?

Do analysts prefer HIMS or MD?

Which has more risk and volatility, HIMS or MD?

Do institutionals & insiders believe in HIMS or MD?

Which has higher earnings and valuation, HIMS or MD?

Summary

How does Pediatrix Medical Group compare to Hinge Health?

Is MD or HNGE more profitable?

Which has better earnings and valuation, MD or HNGE?

Do institutionals and insiders hold more shares of MD or HNGE?

Which has more volatility and risk, MD or HNGE?

Does the media prefer MD or HNGE?

Do analysts prefer MD or HNGE?

Summary

How does Pediatrix Medical Group compare to Chemed?

Is MD or CHE more profitable?

Do institutionals & insiders hold more shares of MD or CHE?

Do analysts prefer MD or CHE?

Which has more volatility & risk, MD or CHE?

Which has preferable valuation and earnings, MD or CHE?

Does the media favor MD or CHE?

Summary

How does Pediatrix Medical Group compare to RadNet?

Do analysts prefer RDNT or MD?

Is RDNT or MD more profitable?

Which has stronger earnings & valuation, RDNT or MD?

Which has more risk and volatility, RDNT or MD?

Does the media favor RDNT or MD?

Do insiders & institutionals hold more shares of RDNT or MD?

Summary

How does Pediatrix Medical Group compare to Billiontoone?

Do insiders and institutionals have more ownership in MD or BLLN?

Does the media refer more to MD or BLLN?

Do analysts prefer MD or BLLN?

Which has preferable valuation & earnings, MD or BLLN?

Is MD or BLLN more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MD vs. The Competition

Pediatrix Medical Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools